diamorphine hydrochloride 5mg for injection
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - diamorphine hydrochloride - powder for injection - diamorphine hydrochloride 5 mg - other nervous system drugs
diacetylmorphine hydrochloride powder for solution
pharmascience inc - diamorphine hydrochloride - powder for solution - 200mg - diamorphine hydrochloride 200mg
diacetylmorphine hydrochloride powder for solution
pharmascience inc - diamorphine hydrochloride - powder for solution - 5000mg - diamorphine hydrochloride 5000mg
morphine jn morphine hydrochloride trihydrate 10 mg/1 ml solution for injection ampoule
juno pharmaceuticals pty ltd - morphine hydrochloride trihydrate -
morphine jn morphine hydrochloride trihydrate 20 mg/1 ml solution for injection ampoule
juno pharmaceuticals pty ltd - morphine hydrochloride trihydrate -
morphine jn morphine hydrochloride trihydrate 50 mg/5 ml solution for injection ampoule
juno pharmaceuticals pty ltd - morphine hydrochloride trihydrate -
morphine jn morphine hydrochloride trihydrate 100 mg/5 ml solution for injection ampoule
juno pharmaceuticals pty ltd - morphine hydrochloride trihydrate -
apomine apomorphine hydrochloride hemihydrate 100 mg/20 ml solution for infusion vial
interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
movapo pfs apomorphine hydrochloride hemihydrate 50mg/10ml solution for subcutaneous infusion pre-filled syringe
stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.
apomorphine emetic tablets
jurox pty limited - apomorphine hydrochloride - oral tablet - apomorphine hydrochloride alkaloid active 6.5 mg/tb - central nervous system - dog | bitch | castrate | puppy - emetic | induce vomiting